Efficacy and Safety of Pseudolaric Acid B Against and in a Murine Infection Model

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2025 Feb 13

PMID 39944494

Authors

Zhuo-Ma Dawa

Ting Zhai

Chuan-Chuan Liu

Hai-Ning Fan

Affiliations

Soon will be listed here.

Abstract

Introduction: Alveolar echinococcosis (AE) is a chronic zoonotic disease caused by the larvae of the (). The current chemotherapy for AE relies on albendazole and mebendazole, which exhibit only parasitostatic rather than parasiticidal effects. Therefore, there is a need to find new anti-Echinococcosis drugs. Pseudolaric acid B (PAB) has been described to have strong antiparasitic effects. However, the in-depth mechanism by which PAB acts against remains unclear.

Methods: To evaluate the effect of a PAB intervention on protoscoleces, metacestode vesicles and germinal cells in . In addition, the effects of PAB on T lymphocyte and collagen synthesis were evaluated after PAB administration in a mouse model.

Results: Metacestode vesicles and germinal cells were successfully cultured, and specific genes were amplified via RT-PCR to identify the protoscoleces, vesicles, and germinal cells as the sources of . studies have demonstrated that PAB exhibits dose- and concentration-dependent cytotoxicity against protoscoleces. Scanning electron microscopy revealed that the microvilli structure of the protoscolex was destroyed and the rostellar hooks had fallen off. PAB induced. The release of PGI from the metacestode vesicles, leading to the structural destruction of the inner surfaces. PAB suppressed the proliferation of germinal cells. After PAB treatment, the serum and the host tissue surrounding the metacestodes IFN- levels were upregulated and the IL-4 and IL-10 levels was downregulated. After PAB treatment, the levels of CD4 T lymphocytes increased and the levels of CD8 T lymphocytes decreased in the host tissue surrounding the metacestodes and the spleen. The proportions of the Th1 and Th17 cell subpopulations were increased and the proportion of Th2 cell and Treg cell subpopulations was decreased in the host tissue surrounding the metacestodes. Additionally, collagen deposition was increased after PAB treatment. PAB suppressed the expression of matrix metalloproteinases (MMPs 1, 2, 3, 9, 13) and the activation of the PI3K/AKT signaling pathway in the host tissue surrounding the metacestodes.

Conclusion: PAB has a significant killing effect on , suggesting that it is a potential candidate for the treatment of AE.

References

Li T, Chen H, Yang Z, Wei N, Zhang S, Mei X . Topical application of Pseudolaric acid B improve DNFB-induced contact hypersensitivity via regulating the balance of Th1/Th17/Treg cell subsets. Eur J Pharm Sci. 2012; 45(5):668-76. DOI: 10.1016/j.ejps.2012.01.005. View

Hemphill A, Stettler M, Walker M, Siles-Lucas M, Fink R, Gottstein B . Culture of Echinococcus multilocularis metacestodes: an alternative to animal use. Trends Parasitol. 2002; 18(10):445-51. DOI: 10.1016/s1471-4922(02)02346-2. View

Lee Y, Cheng T, Lee J, Chen J, Liao Y, Fong Y . Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell Biochem. 2010; 347(1-2):103-15. DOI: 10.1007/s11010-010-0618-z. View

Gao H, Huo L, Mo X, Jiang B, Luo Y, Xu B . Suppressive effect of pseudolaric acid B on involving regulation of TGF-β1 signaling and . Front Microbiol. 2022; 13:1008274. PMC: 9691991. DOI: 10.3389/fmicb.2022.1008274. View

Zou S, Parfenova E, Vrdoljak N, Minden M, Spagnuolo P . Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells. Int J Mol Sci. 2024; 25(12). PMC: 11203802. DOI: 10.3390/ijms25126517. View

Liu Q, Yang Q, Wu Z, Chen Y, Xu M, Zhang H . IL-1β-activated mTORC2 promotes accumulation of IFN-γ γδ T cells by upregulating CXCR3 to restrict hepatic fibrosis. Cell Death Dis. 2022; 13(4):289. PMC: 8971410. DOI: 10.1038/s41419-022-04739-3. View

Brehm K, Koziol U . On the importance of targeting parasite stem cells in anti-echinococcosis drug development. Parasite. 2014; 21:72. PMC: 4271656. DOI: 10.1051/parasite/2014070. View

Kern P, Menezes da Silva A, Akhan O, Mullhaupt B, Vizcaychipi K, Budke C . The Echinococcoses: Diagnosis, Clinical Management and Burden of Disease. Adv Parasitol. 2017; 96:259-369. DOI: 10.1016/bs.apar.2016.09.006. View

Stadelmann B, Scholl S, Muller J, Hemphill A . Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes. J Antimicrob Chemother. 2010; 65(3):512-9. DOI: 10.1093/jac/dkp490. View

10.

Stadelmann B, Spiliotis M, Muller J, Scholl S, Muller N, Gottstein B . Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions. Int J Parasitol. 2010; 40(13):1563-74. DOI: 10.1016/j.ijpara.2010.05.009. View

11.

Spiliotis M, Mizukami C, Oku Y, Kiss F, Brehm K, Gottstein B . Echinococcus multilocularis primary cells: improved isolation, small-scale cultivation and RNA interference. Mol Biochem Parasitol. 2010; 174(1):83-7. DOI: 10.1016/j.molbiopara.2010.07.001. View

12.

Deplazes P, Rinaldi L, Alvarez Rojas C, Torgerson P, Harandi M, Romig T . Global Distribution of Alveolar and Cystic Echinococcosis. Adv Parasitol. 2017; 95:315-493. DOI: 10.1016/bs.apar.2016.11.001. View

13.

Zhu J, Paul W . Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010; 238(1):247-62. PMC: 2975272. DOI: 10.1111/j.1600-065X.2010.00951.x. View

14.

Sun T, Yang Y, Qiu Y, Wang T, Yang M, Shen S . High PD-1 and CTLA-4 expression correlates with host immune suppression in patients and a mouse model infected with Echinococcus multilocularis. Parasit Vectors. 2024; 17(1):437. PMC: 11515268. DOI: 10.1186/s13071-024-06511-2. View

15.

Chowdhury A, Nosoudi N, Karamched S, Parasaram V, Vyavahare N . Polyphenol treatments increase elastin and collagen deposition by human dermal fibroblasts; Implications to improve skin health. J Dermatol Sci. 2021; 102(2):94-100. DOI: 10.1016/j.jdermsci.2021.03.002. View

16.

Stadelmann B, Aeschbacher D, Huber C, Spiliotis M, Muller J, Hemphill A . Profound activity of the anti-cancer drug bortezomib against Echinococcus multilocularis metacestodes identifies the proteasome as a novel drug target for cestodes. PLoS Negl Trop Dis. 2014; 8(12):e3352. PMC: 4256282. DOI: 10.1371/journal.pntd.0003352. View

17.

Li K, Gu X, Li P, Zhang Y, Zhao Y, Yao Z . Effect of pseudolaric acid B on gastric cancer cells: inhibition of proliferation and induction of apoptosis. World J Gastroenterol. 2006; 11(48):7555-9. PMC: 4727228. DOI: 10.3748/wjg.v11.i48.7555. View

18.

Nitta S, Hisasue M, Horiguchi Y, Yamada Y, Kikuchi K, Kubo T . Three-dimensional spheroid culture of canine hepatocyte-like cells derived from bone marrow mesenchymal stem cells. Regen Ther. 2021; 15:210-215. PMC: 7770424. DOI: 10.1016/j.reth.2020.09.002. View

19.

Yuan M, Luo Y, Xin Q, Gao H, Zhang G, Jing T . Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo. Vet Parasitol. 2016; 226:38-43. DOI: 10.1016/j.vetpar.2016.05.016. View

20.

Bresson-Hadni S, Vuitton D, Lenys D, Liance M, Racadot E, Miguet J . Cellular immune response in Echinococcus multilocularis infection in humans. I. Lymphocyte reactivity to Echinococcus antigens in patients with alveolar echinococcosis. Clin Exp Immunol. 1989; 78(1):61-6. PMC: 1534585. View